The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for a vaccine for the prevention of COVID-19) in individuals 16 years of age and older.
This EUA enables the experimental Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) to be distributed effectively in the USA.
Read More
